GeoVax reports non-human primate data for Ebola vaccine

GeoVax Labs Inc. (OTCQB:GOVX) reported preclinical data from rhesus macaques challenged with a lethal dose of Ebola virus showing that a single intramuscular dose of GEO-EM01 conferred 100% protection against Ebola virus infection at four weeks post-inoculation, whereas three of four unvaccinated animals died within 12 days. Data were published in Scientific Reports...